ArticleSerum Pentraxin-3 Level in Patients with Rheumatoid Arthritis and its Association with Disease Activity
ArticleSerum Pentraxin-3 Level in Patients with Rheumatoid Arthritis and its Association with Disease Activity
ArticleThe Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients
ArticleThe Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients
ArticlePENTRAXIN 3 AND ATHEROSCLEROSIS IN CHRONIC KIDNEY DISEASE PATIENTS UNDER HAEMODIALYSIS AND RENAL REPLACEMENT TREATMENT
ArticlePENTRAXIN 3 AND ATHEROSCLEROSIS IN CHRONIC KIDNEY DISEASE PATIENTS UNDER HAEMODIALYSIS AND RENAL REPLACEMENT TREATMENT
ArticleSerum Adiponectin Level in Patients with Systemic Lupus Erythematosus and its Correlation with Disease Activity
ArticleSerum Adiponectin Level in Patients with Systemic Lupus Erythematosus and its Correlation with Disease Activity
ArticleStudy of Dyslipidemia in Patients with Systemic Lupus Erythematosus and its Correlation to Disease Activity
ArticleStudy of Dyslipidemia in Patients with Systemic Lupus Erythematosus and its Correlation to Disease Activity
ArticleValue of Speckle Tracking Echocardiography for Early Detection of Left Ventricular Dysfunction in Patients with Systemic Lupus Erythematosus
ArticleValue of Speckle Tracking Echocardiography for Early Detection of Left Ventricular Dysfunction in Patients with Systemic Lupus Erythematosus
ArticleSerum Pentraxin3: Its Relationship with left Ventricular Mass Index and its role as a Predictor for Cardiovascular Mortality in Hemodialysis Patients
ArticleSerum Pentraxin3: Its Relationship with left Ventricular Mass Index and its role as a Predictor for Cardiovascular Mortality in Hemodialysis Patients
ArticleInsulin Resistance in Patients with Lupus Nephritis: Association to Cardiovascular Risk Factors, Disease Activity, and Subclinical Atherosclerosis
ArticleInsulin Resistance in Patients with Lupus Nephritis: Association to Cardiovascular Risk Factors, Disease Activity, and Subclinical Atherosclerosis
ArticleRole of Interleukin-18, S-adenosylmethionine and SAdenosylhomocysteine as Cardiovascular Risk Factors in Patients with Systemic Lupus Erythematosus
ArticleRole of Interleukin-18, S-adenosylmethionine and SAdenosylhomocysteine as Cardiovascular Risk Factors in Patients with Systemic Lupus Erythematosus